Eli Zuckerman
Impact in
- Hepatology top 0.1%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Liver physiology and pathology
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 62
- Hepatitis C virus research 47
- Liver Disease and Transplantation 11
- Epidemiology 16
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 5
- Co-authors
- Daniel Yeshurun (23 shared papers)Elias Toubi (12 shared papers)ITZHAK A. ROSNER (14 shared papers)Gleb Slobodin (9 shared papers)Edmond Sabo (12 shared papers)Jochanan E. Naschitz (11 shared papers)Michael Rozenbaum (11 shared papers)Tsila Zuckerman (5 shared papers)
- Journals
- Journal of Hepatology (16 papers)Liver International (5 papers)Journal of Viral Hepatitis (5 papers)The Lancet (3 papers)Seminars in Arthritis and Rheumatism (3 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Eli Zuckerman
96 papers receiving 7.8k citations
Eli Zuckerman's Hit Papers
Peers
Comparison fields: 5 of 126
- Hepatology 4.8k
- Epidemiology 2.1k
- Oncology 357
- Rheumatology 216
- Pathology and Forensic Medicine 209
Countries citing papers authored by Eli Zuckerman
This map shows the geographic impact of Eli Zuckerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Zuckerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Zuckerman more than expected).
Fields of papers citing papers by Eli Zuckerman
This network shows the impact of papers produced by Eli Zuckerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Zuckerman. The network helps show where Eli Zuckerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli Zuckerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study Hit paper breakdown → | 2016 | 1661 |
| 2 | Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Hit paper breakdown → | 2019 | 1078 |
| 3 | Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study Hit paper breakdown → | 2015 | 554 |
| 4 | Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study Hit paper breakdown → | 2022 | 489 |
| 5 | Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Hit paper breakdown → | 2020 | 414 |
| 6 | 1997 | 338 | |
| 7 | 2011 | 336 | |
| 8 | 2014 | 248 | |
| 9 | 2014 | 242 | |
| 10 | A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease Hit paper breakdown → | 2023 | 168 |
| 11 | Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. | 2000 | 130 |
| 12 | 2015 | 124 | |
| 13 | 2015 | 114 | |
| 14 | 1998 | 94 | |
| 15 | 2023 | 92 | |
| 16 | 1995 | 91 | |
| 17 | 2001 | 90 | |
| 18 | 2015 | 87 | |
| 19 | 2015 | 85 | |
| 20 | 1996 | 76 |
About Eli Zuckerman
Eli Zuckerman is a scholar working on Hepatology, Epidemiology, Rheumatology, Surgery and Oncology, having authored 97 papers that have together received 8.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (47 papers), Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (5 papers), Cardiovascular Syncope and Autonomic Disorders (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Viral-associated cancers and disorders (3 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). The work is most often cited by research in Hepatology (4.8k citations), Epidemiology (2.1k citations), Oncology (357 citations), Rheumatology (216 citations) and Pathology and Forensic Medicine (209 citations). Eli Zuckerman has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Daniel Yeshurun, Elias Toubi, ITZHAK A. ROSNER, Gleb Slobodin, Edmond Sabo, Jochanan E. Naschitz, Michael Rozenbaum, Tsila Zuckerman, Janice Wahl and Michael N. Robertson. Their work appears in journals such as Journal of Hepatology, Liver International, Journal of Viral Hepatitis, The Lancet and Seminars in Arthritis and Rheumatism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.